Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 14Breast Neoplasms 3Metastatic Castration-resistant Prostate Cancer 2Carcinoma, Non-Small-Cell Lung 2Prostate Cancer Metastatic to Bone 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Multiple Myeloma 1Lung Neoplasms 1Hormone Refractory Prostate Cancer 1Bone Metastases 1

Interventions

radium Ra 223 dichloride 1Fentanyl 1Exercise 1Docetaxel 1Continuous Glucose Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bone Metastases × radium Ra 223 dichloride × Clear all
NCT01106352 2017-01-04

A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)

Bayer

Phase 1/2 Completed
70 enrolled 26 charts
Genitourinary

Bone Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡